ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.652,67
0,44%
S&P 500
5.352,96
-0,02%
Dow Jones
38.886,17
0,20%
Euro vs US Dollar
1,0892
0,17%
Bitcoin
70.866,21
-0,30%
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ
  6. Zivo Bioscience Inc (ZIVO)

  7. Zivo Bioscience Inc (ZIVO) News

ZIVO

Zivo Bioscience (ZIVO)

Zivo Bioscience Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:ZIVO
DatumZeitQuelleÜberschriftSymbolFirma
07/06/202400h30Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
07/06/202400h28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
07/06/202400h27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
07/06/202400h26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
07/06/202400h25Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
06/06/202422h54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
04/06/202423h16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
13/05/202422h38Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZIVOZivo Bioscience Inc
26/04/202419h36Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ZIVOZivo Bioscience Inc
26/04/202414h05Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:ZIVOZivo Bioscience Inc
26/04/202414h00Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ZIVOZivo Bioscience Inc
09/04/202417h49Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
14/03/202414h16Edgar (US Regulatory)Form SCHEDULE 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
15/02/202422h45Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
15/02/202414h54Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:ZIVOZivo Bioscience Inc
07/02/202422h54Business WireZIVO Bioscience Reports Additional Findings from Positive 42-Day Coccidiosis Challenge StudyNASDAQ:ZIVOZivo Bioscience Inc
29/01/202414h00Business WireZIVO Bioscience Announces Uplisting to OTCQB MarketNASDAQ:ZIVOZivo Bioscience Inc
22/01/202423h15Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:ZIVOZivo Bioscience Inc
17/01/202422h11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
05/01/202423h17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
04/01/202422h05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
03/01/202423h23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
02/01/202422h12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ZIVOZivo Bioscience Inc
27/11/202315h29Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
22/11/202322h21Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
13/11/202322h18Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ZIVOZivo Bioscience Inc
03/11/202315h18Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
30/10/202318h20Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:ZIVOZivo Bioscience Inc
30/10/202313h30Business WireZIVO Bioscience Initiates 42-Day Validation Study with Immune-Modulating Product for the Prevention and Treatment of Coccidiosis in Broiler ChickensNASDAQ:ZIVOZivo Bioscience Inc
26/10/202314h56Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ZIVOZivo Bioscience Inc
 Showing the most relevant articles for your search:NASDAQ:ZIVO

Kürzlich von Ihnen besucht

BOV
CEEB3R
COELBA ON
LSE
BW90
Asian Inf.34
NASDAQ
FEPI
REX FANG and Innovation ...
COIN
37CUST
37Protocol
USOTC
KSUEF
Kanematsu Electronics (CE)
ASX
OBJNB
OBJ
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten